타액선 감염 시장 규모
세계 타액선 감염 시장 규모는 2023년 29억 3,000만 달러, 2032년까지 47억 2,000만 달러에 달할 것으로 예상되며, 2024-2032년 연평균 5.44% 성장할 것으로 예상됩니다. 시장은 주로 질병 패턴의 변화, 환경 변화, 다양한 타액선 감염증의 유행 등으로 인해 성장할 것으로 예상됩니다. 연구개발 및 임상시험에 대한 자금 조달 증가로 인한 제품 개발의 향상도 시장 확대의 중요한 촉진요인입니다. 시장은 주로 진단 및 치료 옵션의 발전, 자기 관리 인식의 향상, 위생 습관의 개선에 의해 주도될 것입니다.
세계 타액선 감염의 개요
타액선 감염은 타액선이나 타액관이 박테리아나 바이러스에 감염되어 발생합니다. 타액의 흐름 감소는 타액관의 막힘이나 염증으로 인해 발생할 수 있으며, 이는 감염의 원인이 될 수 있습니다. 이 질환은 타액선염으로 알려져 있습니다. 타액선 감염은 영유아를 포함한 모든 사람에게 발생할 수 있지만, 특히 노인과 장기적으로 질병을 앓고 있는 사람들이 더 취약한 질환입니다. 타액선염으로 알려진 질환은 하나 이상의 타액선이 부어오르고 염증이 생기는 것이 특징입니다. 급성형과 만성형이 모두 존재합니다. 타액선염의 정확한 원인은 알려져 있지 않습니다. 타액선 결석증, 즉 타액선 결석 생성은 때때로 이 질환과 관련이 있을 수 있습니다.
타액선염의 결과로 하나 이상의 타액선이 부어 오르거나 민감해지거나 붉어질 수 있습니다. 타액선에는 귀 근처의 귀밑샘, 혀밑샘, 턱밑샘과 혀, 입술, 뺨, 구개에 있는 여러 개의 작은 샘이 포함됩니다. 이 땀샘의 분비물은 타액석 또는 결석에 의해 방해받을 수 있습니다.
때로는 타액선이 감염되어 열이 나는 등 증상이 나타나기도 합니다. 급성 및 만성 타액선염의 공통적인 특징은 타액의 흐름이 감소한다는 것입니다. 식사 중 통증이 두드러지며, 환자의 75% 이상이 구강건조증을 호소합니다. 다른 질환으로는 유육종증, 탈수, 영양실조, 암 방사선 치료, 헤르페스, HIV, A형/II형 독감, I형/II형 인플루엔자, 타액 결석, 타액관을 막는 점액, 종양, 쇼그렌 증후군, 유육종증, 불충분한 구강 위생 등이 있습니다. 타액 분비를 감소시켜 타액선염을 유발할 수 있습니다.
타액선 감염 시장 성장 촉진요인
감염률 상승
타액선 감염에 대한 대체 치료법에 대한 요구는 대부분 감염, 특히 세균, 곰팡이 및 바이러스 감염의 유행으로 인해 발생합니다. 곰팡이 감염, 세균성 타액선염, 유행성 이하선염과 같은 질병의 유병률은 치아 불결, 생활 습관의 변화, 항생제 내성 박테리아의 출현으로 인해 빈번하게 증가하고 있습니다. 이러한 사례의 증가는 효율적인 치료 및 진단 접근법의 필요성을 분명히 보여줍니다.
타액선 건강의 중요성에 대한 지식이 증가함에 따라 의료진은 이러한 감염 질환의 식별과 치료에 더 많은 관심을 기울이고 있습니다. 이러한 관심의 증가로 인해 환자들은 더 일찍 치료를 받고 있으며, 최첨단 치료 옵션에 대한 수요가 증가하고 있습니다. 또한, 환자 예후를 개선하기 위한 연구 활동의 활성화와 치료 기술의 발전은 시장 성장 잠재력을 강화할 것입니다.
타액선 감염 시장 개요 : 지역별
다양한 발전 촉진요인과 장애물이 있는 가운데 세계 타액선 감염 시장은 모든 지역에서 전반적으로 성장하고 있습니다. 치료 옵션이 더 널리 알려지고 쉽게 접근 할 수있는 한 업계는 발전 할 것으로 예상됩니다.
타액선 감염 기업 뉴스
2022년 8월, 호주에서 세계 최초로 암과 심장병의 위험을 검사하는 DNA 검사 프로그램이 도입됐습니다. 이 노력은 호주 모나쉬 대학이 주도하는 전국적인 공동 연구입니다.
2022년 6월, 굿바디헬스(Goodbody Health Inc.)는 유전자 분석을 통해 개인의 심장병 및 암 발병 위험을 10년간 추정할 수 있는 4가지 새로운 검사를 도입했습니다. 이러한 시작은 이 부문의 미래 성장을 가속화할 것으로 예상됩니다.
세계 타액선 감염 시장을 조사했으며, 시장 규모와 성장률, 성장 촉진요인 및 과제, 지역별 시장 점유율, 주요 기업 분석 등의 정보를 전해드립니다.
Salivary Gland Infection Market Size
The Salivary Gland Infection market is expected to reach US$ 2.93 Billion in 2023 to US$ 4.72 Billion by 2032, with a CAGR of 5.44 % from 2024 to 2032. The market is expected to rise due in large part to changing disease patterns, environmental changes, and the rising prevalence of various salivary gland infections. Improved product development as a result of increased financing for R&D and clinical trials is another important driver of market expansion. The market is mostly driven by advances in diagnosis and treatment choices, more self-care awareness, and improved hygiene practices.
Global Salivary Gland Infection Overview
A salivary gland infection happens when the salivary gland or duct is infected by bacteria or viruses. Reduced saliva flow, which may be brought on by an obstruction or inflammation of the salivary duct, may be the cause of the infection. The illness is known as sialadenitis. While salivary gland infections can strike anybody, including infants, the elderly and those with long-term illnesses are particularly vulnerable to the ailment. The illness known as salivalentitis is typified by swelling and inflammation of one or more salivary glands. Both acute and chronic versions exist. Unknown is the precise cause of sialadenitis. Sialolithiasis, or the production of salivary gland stones, may occasionally be linked to the disorder.
One or more salivary glands may swell, become sensitive, or become red as a result of sialadenitis. These include several tiny glands in the tongue, lips, cheeks, and palate in addition to the mouth's parotid, sublingual, and submaxillary glands, which are situated close to the ear. Any of these glands' secretions may be obstructed by salivary stones, or calculi.
Occasionally, the gland may get infected, resulting in fever and other problems. A characteristic shared by both the acute and chronic forms of sialadenitis is decreased salivary flow. During eating, the pain is more noticeable, and over 75% of patients report having dry mouth (xerostomia). Additional medical conditions include sarcoidosis, dehydration, malnutrition, radiation treatment for cancer, herpes, HIV, influenza A and type II, parainfluenza types I and II, salivary stones, mucus-blocking salivary ducts, tumors, Sjogren's syndrome, sarcoidosis, and inadequate oral hygiene, which can reduce salivary production and cause sialadenitis.
Growth Drivers for the Salivary Gland Infection Market
Rising infection rates
The need for treatment alternatives for salivary gland infections is mostly driven by the rising prevalence of infections, especially bacterial, fungal, and viral infections. The prevalence of illnesses such fungal infections, bacterial sialadenitis, and the mumps is rising, frequently as a result of poor dental hygiene, changing lifestyles, and the emergence of germs resistant to antibiotics. The increase in instances emphasizes the necessity of efficient therapeutic and diagnostic approaches.
Healthcare professionals are becoming more alert in identifying and treating these infections as knowledge of the significance of salivary gland health develops. Patients are encouraged to seek medical attention earlier as a result of this increased focus, which increases demand for cutting-edge treatment choices. Furthermore, the market's development potential is reinforced by the increased research activities and advancements in therapeutic technologies aimed at improving patient outcomes.
Improvements in lifestyle
Changes in lifestyle, such as nutrition and stress levels, have a big effect on dental health and raise the risk of salivary gland infections. Poor dental hygiene can result from diets heavy in sugar and processed foods, which in turn encourages bacterial development and raises the risk of illnesses. Furthermore, problems with the salivary glands can be made worse by dehydration and decreased salivation-both of which are prevalent in people who lead unhealthy lives.
Moreover, it is well recognized that high stress levels impair immune function, leaving people more vulnerable to illnesses. Prolonged stress can cause bad habits like teeth grinding, which can harm salivary gland function. The demand for efficient treatment choices is rising in tandem with the growing knowledge of these lifestyle-related dangers, underscoring the necessity of novel therapeutics to address these health issues.
Salivary Gland Infection Market Overview by Regions
With different development drivers and obstacles, the worldwide market for salivary gland infections is generally rising across all geographies. The industry is expected to develop as long as treatment choices become more widely known and accessible. An overview of the market by region is given below:
North America Salivary Gland Infection Market
United States
The increasing prevalence of illnesses like bacterial sialadenitis and viral infections like mumps has led to a thriving market for salivary gland infections in the US. The availability of efficient diagnostic tools and treatment choices is improved by an advanced healthcare infrastructure and a strong focus on research and innovation. The management of chronic diseases and improved oral health are two areas where early detection and action are aided. Furthermore, an elderly population is more prone to illnesses, which increases demand in the market. Overall, the market for salivary gland infections is expected to rise in the United States due to continual improvements in healthcare.
Europe Salivary Gland Infection Market
Germany
Germany's market for salivary gland infections is steadily expanding due to an older population and rising oral health awareness. There is an increasing need for efficient diagnosis and treatment alternatives due to the rising occurrence of diseases like mumps and sialadenitis. Market expansion is further supported by a concentration on research and development and an advanced healthcare infrastructure. Oral hygiene-related public health efforts improve patient outcomes by facilitating early diagnosis and intervention. Germany is positioned to be a major participant in the European salivary gland infection market as healthcare costs rise.
Asia Pacific Salivary Gland Infection Market
China
China's market for salivary gland infections is expanding significantly due to factors such changing eating patterns, growing urbanization, and growing awareness of oral health. Changes in lifestyle and environmental factors are contributing to an increase in the occurrence of illnesses like sialadenitis. Early infection diagnosis and management are being made easier by advancements in healthcare infrastructure and access to cutting-edge diagnostic and treatment alternatives. Market expansion is further supported by government measures focused at improving public health education. China is emerging as a major participant in the worldwide market for salivary gland infections as the healthcare industry continues to change.
Middle East & Africa Salivary Gland Infection Market
Saudi Arabia
Saudi Arabia's market for salivary gland infections is expanding as a result of improving oral health awareness and the prevalence of illnesses like sialadenitis. Dietary modifications and lifestyle choices are among the factors that increase the likelihood of developing these illnesses. The government's emphasis on enhancing access to specialized services and the infrastructure supporting healthcare improves diagnosis and treatment options. Furthermore, oral hygiene education programs run by public health organizations are essential for early detection and prevention. Saudi Arabia is establishing itself as an emerging market in the field of salivary gland infections as medical technology advances.
Salivary Gland Infection Company Analysis
The major participants in the Salivary Gland Infection market includes AbbVie Inc., Allergan plc., AstraZeneca, FUJIFILM Holdings Corporation, General Electric Company, GlaxoSmithKline plc., Merck & Co, Pfizer Inc., Siemens Healthcare GmbH.
Salivary Gland Infection Company News
In August 2022, t One of the world's first DNA screening programs for cancer and heart disease risk was introduced in Australia with free salivary DNA tests. The initiative is a national collaboration headed by Monash University in Australia.
In June 2022, Goodbody Health Inc. has introduced four new tests that use genetic analysis to estimate an individual's 10-year risk of developing heart disease or cancer. It is anticipated that these launches would accelerate this segment's future growth.
Types- Industry is divided into 2 viewpoints:
Application- Industry is divided into 4 viewpoints:
Countries- Industry is divided into 25 viewpoints:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
All companies have been covered with 5 Viewpoints
Company Analysis
Key Questions Answered in Report: